Swiss court ruling on Biogen/Serono

Two different views of a Geneva court ruling were announced on Monday by Biogen (BGEN) and Serono (SRA). The litigation focuses on SRA's EVIDENCE trial, which compared SRA's Rebif beta interferon and ...